Details Drug Name: Semaglutide (Wegovy) Category: GLP-1 receptor agonist (antidiabetic medication) International Brand: Wegovy Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg Packaging: Single-use, pre-filled pens 4 pens per pack (4-week supply) Dosage Form: Subcutaneous injection Uses: Long-term weight management in adults with obesity Weight reduction in overweight adults with comorbidities such as hypertension or type 2 diabetes Obesity treatment in adolescents aged 12 and above Reduces risk of major cardiovascular events in patients with obesity and heart disease Supports appetite control and calorie intake regulation How It Works: Wegovy is formulated with semaglutide, a compound that replicates the effects of the bodys natural GLP-1 hormone
Other important adverse effects include: Acute pancreatitis : Severe, persistent abdominal pain radiating to the back requires immediate medical attention
These powerful injectables also treat excessive underarm moisture, raise drooping brows, and reduce smokers lines around the mouth
Furthermore, the neutralization of TGF using fresolimumab (GC1008), a human anti-TGF1 monoclonal antibody, has shown successful suppression of liver fibrosis development in mouse models [206,207,208,209]
Calibrate Article published on June 14, 2022 Both Mounjaro (tirzepatide) and Trulicity (dulaglutide) are GLP-1-type drugs indicated for the treatment of type 2 diabetes, but they work in slightly different ways
Weight loss drugs have been on the rise in the last few years, with drugs like Wegovy and Ozempic staying at the forefront